Top Asian Stocks To Buy Right Now

September 9, 2013: U.S. markets opened higher on Monday morning following a good report on consumer sentiment in the eurozone and a booming report on China�� trade surplus. Japan�� second-quarter GDP growth was revised up to 0.9%, which was expected. The rise in China�� trade surplus really gave U.S. markets the shot they needed to get off to a strong start this morning.

Asian and Latin American markets closed higher today, while European markets closed mixed.

WTI crude oil closed down 0.9% at $119.52 a barrel and Brent crude trades down 2.3% at $113.42 as traders mull over a possible end to the tension over Syria�� chemical arsenal.

Tuesday�� calendar includes the following data releases and events (all times Eastern):

7:30 a.m. – National Federation of Independent Business optimism index 10:00 a.m. – Job openings and labor turnover survey (JOLTS) 11:30 a.m. – 4-week bill auction 1:00 p.m. – 3-year note auction

Here are the closing bell levels for Monday:

Hot Insurance Companies To Invest In 2015: Brandenburg Energy Corp (BBM)

Brandenburg Energy Corp. is engaged in the business of acquiring and exploring oil and gas properties. The Company�� properties include Holloman Cooper Basin Joint Venture, VG Mineral Claims, Senn Property, Exploration License No. 0932, Labana Property and African Properties. The Senn Property earns a 100% interest on the Senn Block of mineral claims (the Senn Property) located in the District of Kenora, Ontario, Canada. The Uganda-based East African Gold Sniffing Company Limited (EA Gold) is a holder of Mineral Exploration License No. 0932 (EL 0932) covers about two square kilometers. EL 0932 lies 287 kilometers southwest of the Ugandan capital, Kampala, 29 kilometers north of the city of Kasese, in Kasese province. The Labana Property consists of four oil and gas blocks in the Republic of Niger, which includes Dibeilla 1, Dibeilla 2, Dalo, and Mandaram. Advisors' Opinion:

• [By Muhammad Bazil]

  The value of BlackBerry�� stock was at $7.44 as of yesterday�� (Jan. 1, 2014) close. Although this is still a far cry from its 52-week peak of $18.32, it does represent a month-long recovery coming shortly after the launch of its new BlackBerry Messenger (BBM) application for iPhones and Android devices.

Top Asian Stocks To Buy Right Now: Illumina Inc.(ILMN)

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its instrumentation products include HiSeq 2000, an instrument for high-throughput (up to 200 Gb per run and up to 25 GB per day) sequencing using sequencing-by-synthesis (SBS) technology; Genome Analyzer IIx, an instrument for medium to high-throughput (up to 95 Gb per run) sequencing using SBS technology; Genome Analyzer IIe, an instrument for low to medium throughput (up to 40 Gb per run) sequencing using SBS technology; iScan System, a high-resolution imaging instrument to scan BeadArray based assays; and BeadXpress Reader, a low- to mid-multiplex, high-throughput instrument for readout of assays. The company?s consumables consist of InfiniumHD Whole-Genome BeadChips comprising HumanOmniExpress, HumanOmni1-Quad, Human1M-Duo, and BovineHD, which are multi-sample DNA analysis microarrays; iSelect Custom Genotyping BeadChips that are custome r designable SNP genotyping arrays; GoldenGate Assay Method, a high throughput assay and genotyping system; GoldenGate Universal-32 Sample BeadChip, which are 32 sample GoldenGate genotyping arrays; Paired-End Genomic DNA Sample Prep Kit, a streamlined library preparation kit to generate 200?500 kb insert paired-end reads; VeraCode GoldenGate that are low plex GoldenGate genotyping arrays compatible with the BeadXpress System; Standard Sequencing Kit, reagents used for SBS chemistry on sequencing platforms; and Infinium Assay Kit, reagents used to perform Infinium assays on the iScan platform. It also provides sequencing and genotyping services. The company?s customers include pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies, as well as research centers. It sells its products through distributors in North America, Europe, the Asia-Pacific, the Middle East, and South Africa. Illumina was founded in 1998 and is headquartered in San Dieg o, California.

Advisors' Opinion:

• [By Monica Gerson]

  Illumina (NASDQ: ILMN) is estimated to report its Q3 earnings at $0.40 per share on revenue of $343.56 million.

  Texas Instruments (NASDAQ: TXN) is expected to report its Q3 earnings at $0.53 per share on revenue of $3.23 billion.

• [By Sean Williams]

  What: Shares of Illumina (NASDAQ: ILMN  ) , a life science diagnostics company, rallied as much as 15% after the company reported better-than-expected first-quarter earnings results.

• [By WWW.GURUFOCUS.COM]

  Shares of Illumina, Inc. (ILMN), the leading provider of next generation DNA sequencing instruments and consumables, rose 34% in the first quarter, driven by better than expected fourth quarter financial results, strong 2014 financial guidance, and the announcement of multiple new product introductions, including an ultra-high throughput sequencing platform that will be the first to sequence a full human genome for less than $1,000. We believe Illumina has further distanced itself from its competitors and holds an effective monopoly on DNA sequencing at a time when demand is accelerating.

Top Asian Stocks To Buy Right Now: Arrowhead Research Corporation(ARWR)

Arrowhead Research Corporation, a clinical stage nanomedicine company, through its subsidiaries, develops therapeutic products at the interface of biology and nanoengineering to cure disease and improve human health. It focuses on the design and development of therapeutic agents for the treatment of cancer and obesity, as well as healing wounded or diseased tissue based on nucleic acid delivery, siRNA chemistry, and tissue targeting intellectual properties. The company?s lead products include CALAA-01, an oncology drug candidate based on the gene silencing RNA interference (RNAi) mechanism; and Adipotide, an anti-obesity peptide that targets and kills the blood vessels that feed white adipose tissue. It also plans to develop its internal preclinical and clinical pipeline, including RONDEL-enabled siRNA drug candidates, Dynamic Polyconjugate (DPC)-enabled drug candidate development, and the non-siRNA-based anti-obesity drug candidate, Adipotide. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.

Advisors' Opinion:

• [By Roberto Pedone]

  Another under-$10 nanotechnology player that's quickly moving within range of triggering a big breakout trade is Arrowhead Research (ARWR), which forms, acquires and operates subsidiaries commercializing innovative nanotechnologies. This stock has been on fire so far in 2013, with shares up a whopping 284%.

  If you take a look at the chart for Arrowhead Research, you'll notice that this stock has been uptrending strong for the last five months, with shares soaring higher from its low of $1.81 to its recent high of $8.88 a share. During that uptrend, shares of ARWR have been consistently making higher lows and higher highs, which is bullish technical price action. Shares of ARWR took out some near-term overhead resistance levels on Friday at $7.84 to $7.99 a share. That move is now quickly pushing shares of ARWR within range of triggering another big breakout trade.

  Market players should now look for long-biased trades in ARWR if it manages to break out above Friday's high of $8.37 a share to its 52-week high at $8.88 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 500,600 shares. If that breakout hits soon, then ARWR will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets off that breakout are $11 to $12 a share.

  Traders can look to buy ARWR off weakness to anticipate that breakout and simply use a stop that sits right around its 50-day moving average of $7.10 a share. One can also buy ARWR off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By GuruFocus]

  George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated

Top Asian Stocks To Buy Right Now: Central Securities Corp (CET)

Central Securities Corporation is a non-diversified, closed-end management investment company. The Company�� primary investment objective is growth of capital. Central Securities Corporation invests primarily in common stocks, but it may invest in bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks and corporations.

The Company, from time to time, invests in securities, the resale of which is restricted. Central Securities Corporation invests in various sectors, including insurance, Semiconductor, Technology Hardware and Equipment, Diversified Industrial, Energy, Software and Services, Banking and Finance and other.

Advisors' Opinion:

• [By Joe Eqcome]

  Actionable Items:

  Highest Positive Spread: ING Emerging Markets High Dividend Equity Fund (IHD)Focus Stock: Central Securities Corporation (CET)Last Week's Focus Stock: Central Securities Corporation

  Junk Bonds Debacle: The $85 billion monthly bond-purchase program has produced a selloff for "junk" bonds. The U.S. Treasurys jumped 0.18% to 4.39% on Wednesday. The benchmark 10-Year Treasury note has risen 0.5% in the past month.

Top Asian Stocks To Buy Right Now: Home Federal Bancorp Inc. of Louisiana(HFBL)

Home Federal Bancorp, Inc. of Louisiana operates as the holding company for Home Federal Bank, which provides financial services to individuals, corporate entities, and other organizations in northwest Louisiana. The company?s deposit products include savings accounts, NOW accounts, money market accounts, and certificate accounts, as well as passbook savings, certificates of deposit, and demand deposit accounts. Its loan portfolio comprises real estate loans, such as one to four family residential loans; commercial-real estate loans; multi-family residential loans; commercial business loans; land loans; construction loans; home equity and second mortgage loans; equity lines of credit; and consumer loans, including loans secured by deposit accounts, automobile loans, and other unsecured loans. The company also offers wealth management services. As of December 7, 2010, it operated through its main office, two branch offices, and one agency office in Shreveport, Louisiana. T he company is based in Shreveport, Louisiana.

Advisors' Opinion:

• [By Lauren Pollock]

  Bank-holding company Banner Corp.(BANR) on Tuesday said it had agreed to buy Home Federal Bancorp Inc.(HFBL) (HOME) for $197 million in cash and stock. The deal, expected to close in the first quarter of 2014, will result in a combined company with about $5.2 billion in assets, making it the fourth-largest bank in the Pacific Northwest by assets, the companies said.

Top Asian Stocks To Buy Right Now: VizStar Inc (VIZS)

VizStar, Inc. (VizStar), formerly Easy CD Yearbook, Inc., incorporated on June 27, 2006, is a development-stage company. The Company focuses to market software, which enables schools, clubs and organizations to produce their own multimedia yearbook. On June 11, 2010, Celestial Jets, Inc. (Celestial Jets) merged with the Company. Celestial Jets merged (the merger) with and into the Company�� wholly owned subsidiary, Celestial Acquisition Corp. Upon the merger, the name of Celestial Acquisition Corp. became Celestial Jets, Inc. In December 2012, the Company acquired Kimberly Parry Corporation.

A multimedia yearbook is a compact disc (CD)/ digital versatile disc (DVD), which contains video, photos, audio and text that is personal computer (PC) and Mac compatible. As of May 31, 2010, the Company had no revenues.

The Company competes with Yeardisk, Digital Journey LLC and Interactive Software Designs.

Advisors' Opinion:

• [By Peter Graham]

  Small cap stocks VizStar Inc (OTCMKTS: VIZS), SOHM Inc (OTCMKTS: SHMN) and American Soil Technologies, Inc (OTCMKTS: SOYL) have been getting some attention in various investment newsletters with two out of three of these stocks being the subject of paid promotions. However, there is nothing wrong with some paid for attention so long as everything is properly disclosed, but its going to be up to investors and traders alike to ultimately decide whether any of these stocks have what it takes to be the next hot stock. With that in mind, here is a quick reality check about all three small cap stocks:

Top Asian Stocks To Buy Right Now: MannKind Corporation(MNKD)

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States, Europe, and Asia. Its lead product candidate, AFREZZA Inhalation Powder, an ultra rapid-acting insulin that is in Phase III clinical trials for the treatment of diabetes for the control of hyperglycemia. The company also develops MKC1106-MT, an investigational cancer immunotherapy product, which is in Phase II clinical trials for the treatment of adults with type 1 or type 2 diabetes; and MKC204, which is in preclinical development stage for the treatment of malignancies and inflammatory diseases. In addition, its products include MKC253 (GLP-1), a Phase I clinical trials product for the treatment of type 2 diabetes; MKC1106-PP, a Phase I clinical trials product for diverse tumor types, metastatic disease, and/or progressive and refractory disease; and MKC180, an obesity compound and MKC1106-NS , a cancer immunotherapy product that are in preclinical trials. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.

Advisors' Opinion:

• [By Keith Speights]

  Perennial underdog MannKind (NASDAQ: MNKD  ) could be on its countdown to liftoff. The company announced its first-quarter results after the market closed on Thursday. Here is the countdown of the highlights -- from least to most important.

• [By Eddie Staley]

  Equities Trading DOWN
  Shares of MannKind (NASDAQ: MNKD) were down 11.30 percent to $6.28 after the company announced a tentative date of the FDA advisory committee review of AFREZZA.